UNIGE document Scientific Article
previous document  unige:98666  next document
add to browser collection

Indications off-label des traitements biologiques en dermatologie

Published in Revue médicale suisse. 2016, vol. 12, no. 512, p. 635-8
Abstract Last years, the development of biological drugs substantially improved the outcome of many inflammatory diseases. In dermatology, this kind of therapy is essentially prescribed for the treatment of psoriasis, and include the anti-TNF, anti-IL-12/IL-23 and anti-IL-17. Despite these treatments have not yet been approved, they seemed to be efficient for the treatment of many other inflammatory dermatosis, like granulomatous diseases, neutrophilic diseases, hydradenitis suppurativa or pityriasis rubra pilaris.
Keywords Biological Products/therapeutic useDermatology/trendsGranuloma/drug therapyHumansOff-Label UsePityriasis Rubra Pilaris/drug therapyPsoriasis/drug therapySkin Diseases/drug therapy
PMID: 27172693
Full text
Article (Published version) (11.2 MB) - public document Free access
Research group Mécanismes des pathologies de l'inflammation cutanée (919)
(ISO format)
CORTES SANCHEZ, Begonia, LAFFITTE, Emmanuel Alexis. Indications off-label des traitements biologiques en dermatologie. In: Revue médicale suisse, 2016, vol. 12, n° 512, p. 635-8. https://archive-ouverte.unige.ch/unige:98666

238 hits



Deposited on : 2017-11-07

Export document
Format :
Citation style :